Recently, two perspectives on merit-based hirings were presented. Lydia Polgreen deplored the increasing attacks on the ...
ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
Lawmakers and Indiana’s education secretary preview legislative priorities that are likely to be debated in the coming weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback